Refine by
Pharmaceutical Market Articles & Analysis
52 news found
Always innovative and outstanding, Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building blocks, nucleosides, intermediates and Active Pharmaceutical Ingredients (APIs). ...
Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain. ...
These new products are introduced to meet the growing demands of the pharmaceutical market. Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. ...
® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the fourth quarter ended December 31, 2022, after the close of the financial markets on Thursday, March 16, 2023 and will hold a conference call at 4:30 p.m. ...
The U.S. Food and Drug Administration recently completed its regulatory inspection of the production site in Berlin and issued FARCO-PHARMA approval for the marketing of a sterile lubricant in disposable syringes in the United States. FARCO-PHARMA has been producing and selling the sterile catheter lubricant under the brand name GLYDO® on the U.S. market since October 2014. Medicinal ...
The International Society for Pharmaceutical Engineering is a long-established society that leads in the advancement of scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. ...
Cellworks Group Inc., a leader in Personalized Therapy Biosimulation, today announced the launch of its Precision Drug Development business units aimed at accelerating time-to-market for drug development and reviving previously studied but unapproved pharmaceutical assets through predictive biosimulation. The two new business units will use Cellworks’ ...
Distearyl phthalic acid amide, also known as N, N-Stearyl phthalic acid amide or N, N-Tollow phthalic acid amide, is proven to be applicable for manufacturing some cosmetics or pharmaceuticals. They can function as emulsifiers, suspending agents for cosmetics, triglycerides, mineral oil, silicones, and surfactants for pharmaceuticals. According to a ...
(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has executed a Master Services Agreement (MSA) with Societal CDMO, Inc. ...
Mitochondrial dysfunction has been linked to a variety of market therapeutics and pathological diseases. Therefore, studying or maintaining mitochondrial health is paramount to cell health. ...
MerLion Pharmaceuticals GmbH (MerLion), a pharmaceutical company focused on the development of novel antibiotics, reported the receipt of the final meeting minutes from the U.S. ...
Chimeric’s CEO and Managing Director Jennifer Chow said: “We are delighted to have patent protection granted for CLTX CAR therapies in Japan, the third largest pharmaceutical market in the world¹. The granting of this key Japan patent continues to expand the robust intellectual property portfolio underpinning our CLTX CAR pipeline ...
In the financing round on Companisto, the pharmaceutical company DERMAGO GmbH received an investment commitment of just under 2 million euros within only a few weeks. More than 750 private investors participated in the pharmaceutical company, which has already launched 2 out of 3 reimbursable pharmaceuticals for international distribution on the ...
Learn more about InMed’s INM-755 EB study: https://www.inmedpharma.com/pharmaceutical/inm-755-for-epidermolysis-bullosa/ What is epidermolysis bullosa? ...
According to statistics, only 10% of new drug products in preclinical formulation development successfully reach the market. Therefore, CD Formulation provides the following four services to assist pharmaceutical companies conduct their drug formulation projects. ...
Canadian biotechnology company ANGANY (www.ANGANY.com) is presenting its immunotherapy platform at BIO International Convention, a critical rendez-vous for the global pharmaceutical industry which takes place in San Diego, California between June 13th and 16th. ...
As this market continues to mature, we are well positioned to be a leading supplier of rare cannabinoids to the health and wellness industry. ...
About Vifor Pharma Group Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency and nephrology. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions across iron, dialysis, nephrology and rare conditions. ...
The alliance will focus on leveraging Helixrus' deep knowledge of the Korean pharmaceutical market, and extensive network of relationships in Asian markets, to highlight CytoReason's capabilities in prioritizing new targets, finding biomarkers, profiling combinations, stratifying patients, and other use cases within the drug lifecycle. ...
The new patent protects the i-body sequence used in AdAlta's lead product, AD-214, sequences similar to this, and pharmaceutical compositions and derivatives containing these i-body sequences. ...